Led by KPWHRI scientists, the study, “Predicting Suicide Attempts and Suicide Death Following Outpatient Visits Using Electronic Health Records,” aims to target those who need interventions most.
Clinicians and staff at Kaiser Permanente's Tacoma South clinic describe the many ways Behavioral Health Integration is making a difference for patients.
Whether you try antidepressants, therapy, both, or neither, KPWHRI’s Dr. Gregory Simon points to 3 ‘active ingredients’ for feeling better.
With support from the Garfield Memorial Fund, Kaiser Permanente researchers are using big data to help customize and improve care for depression
The holiday season can be a joyous time for many. But it can also bring on some not-so-healthy behaviors such as too much alcohol, overeating, emotional stress, and even depression.
In a group interview, GHRI mental health scientists describe how their work with UW psychiatry researchers changed treatment worldwide.
With $10 million from NIMH, KPWHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
Research at Kaiser Permanente points to bupropion (Wellbutrin) as first choice for overweight and obese patients with depression.
Randomized controlled trial including peer support helps patients at Kaiser Permanente and Swedish Medical Center.
Kaiser Permanente scientists are leading a groundbreaking research study involving 20,000 patients to find out how to help people who are at risk for suicide.
